Simao TEIXEIRA profile

Simão P. B. Teixeira is a Postdoctoral Researcher in the Domingues Research Group at INL - International Iberian Nanotechnology Laboratory in Braga, Portugal. Simão graduated in Bioengineering (major in Molecular Biotechnology) in 2017 at the University of Porto, having developed his MSc work at TU Dresden (Germany) and the Institute for Research and Innovation in Health (i3S) of U.Porto, focusing on nanotherapies for neural regeneration. In 2024, he obtained his PhD degree in Tissue Engineering, Regenerative Medicine and Stem Cells awarded by the University of Minho with the maximum grade, with a thesis on “Molecular Imprinting Technologies for Growth Factor Sequestration and Control of Stem Cell Fate in Tendon Regeneration”. The PhD project was conducted at the 3B’s Research Group, U.Minho under the supervision of Prof. Manuela E. Gomes and Dr. Rui M. A. Domingues, with research stays at University College London (Eastman Dental Institute) and ETH Zurich (University Hospital Balgrist). He has been involved in major international projects, including Horizon ERC Consolidator Grants MagTendon (772817) and FORTIFy (101171765), and Twinning project Achilles (810850), as well as several national FCT-funded ones. Simão served as student representative of I3Bs in the U.Minho Doctoral College for 2 years. He also participated in the organization of 5 conferences/workshops, including the 31st Annual Meeting of the European Orthopaedic Research Society (EORS 2023) in Porto, Portugal. His early career has thus far yielded 7 published papers (5 as first author) in high impact journals, 1 patent application, 8 oral and 8 poster presentations at international conferences, winning 4 awards, including the prestigious ON/EORS Orthoregeneration Award 2024.

Simão combines expertise in applied chemistry, biology, biochemistry, materials and tissue engineering, among other topics, in order to develop new biotechnological approaches in the healthcare field, with a particular focus on Tissue Engineering and Regenerative Medicine therapeutical startegies. This involves synthesis and characterization of nanoparticles, hydrogels, or biomimetic scaffolds, from both synthetic and natural origins; cell culture and analysis techniques, in 2D and 3D systems; microscopy and image processing, as well as increasing interest in bioinformatic tools to increase the range of capabilities and work output.

https://orcid.org/0000-0003-2764-4319 https://scholar.google.com/citations?user=TjdgbK4AAAAJ&hl=pt-PT